Topic of histopathology blinding in nonclinical safety biomarker qualification studies

Toxicol Pathol. 2010 Jun;38(4):666-7. doi: 10.1177/0192623310371221.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Biomarkers / analysis*
  • Drug Approval
  • Histocytochemistry / methods*
  • Humans
  • ROC Curve
  • Research Design*
  • Toxicity Tests / methods*

Substances

  • Biomarkers